HIV 1 News and Research

RSS

Community-based resources in rural Uganda can successfully provide HIV treatments

New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.

20 Jul 2012

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

A funding analysis released on Wednesday by the Kaiser Family Foundation (KFF) and UNAIDS found that "funding to fight HIV/AIDS in low- and middle-income countries has remained flat at $7.6 billion," Politico Pro reports.

20 Jul 2012

CSIS official discusses upcoming AIDS 2012 conference, introduces new AIDS 2012 course on iTunes U

In this post in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, J. Stephen Morrison, senior vice president of CSIS and director of the CSIS Global Health Policy Center, reflects on the upcoming International AIDS Conference, which opens in Washington, D.C., on Sunday, writing, "It is a choice opportunity in the midst of our bitter electoral season to tell the good news of the extraordinary achievements, at home and abroad, in both science and delivery of effective treatment, care, and prevention to people living with HIV or at risk of infection."

20 Jul 2012

Scientists plan to announce research strategy aimed at pursuing HIV/AIDS cure, Wall Street Journal reports

On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.

20 Jul 2012

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.

20 Jul 2012

International Partnership for Microbicides CEO discusses research in GlobalPost interview

GlobalPost's "Global Pulse" blog features an interview with Zeda Rosenberg, CEO of the International Partnership for Microbicides (IPM), in which she discusses a study of a vaginal ring containing the antiretroviral (ARV) dapivirine.

20 Jul 2012

PBS Newshour shares stories of those affected by HIV/AIDS epidemic

"As Washington prepares to host the International AIDS Conference from July 22-27, PBS NewsHour will profile some of the parallel stories unfolding around the epidemic on opposite ends of the globe," the news service writes. In the first of these stories, the news service profiles two individuals -- John Johnson in Washington, D.C., and Alice Sibanda in Hwange, Zimbabwe -- who as children lost their parents to the HIV/AIDS epidemic.

20 Jul 2012

Single-step method can rapidly detect pathogens and chemical contaminants

Using nanoscale materials, researchers at the University of Georgia have developed a single-step method to rapidly and accurately detect viruses, bacteria and chemical contaminants.

20 Jul 2012

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

We are at a moment of extraordinary optimism in the response to the human immunodeficiency virus (HIV). A series of scientific breakthroughs ... have the potential to markedly expand the available preventive tools. There is evidence of the first cure of an HIV-infected person. And most important, the finding that early initiation of antiretroviral therapy can both improve individual patient outcomes and reduce the risk of HIV transmission to sexual partners by 96% has led many to assert what had so long seemed impossible: that control of the HIV pandemic may be achievable.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

UNMC's ART injectables can successfully treat HIV infection

This has been a good week for breakthroughs in HIV/AIDS. Earlier this week, the Food and Drug Administration approved a daily pill, Truvada, which reduces the risk of HIV infection. Today, a University of Nebraska Medical Center research team's progress toward developing weekly or twice-monthly injectable antiretroviral therapy (ART) nanomedicines for patients with human immunodeficiency virus (HIV) infection will be highlighted as the cover story in the Journal of Infectious Diseases.

19 Jul 2012

AHF: U.S. defends Obama no-show at AIDS conference

On the heels of a White House defense of President Barack Obama's decision to skip the XIX International AIDS Conference in Washington D.C. (Agence France-Presse: "US defends Obama no-show at AIDS Conference," By Kerry Sheridan, July 18, 2012) AIDS Healthcare Foundation (AHF) released a TV ad featuring Archbishop Desmond Tutu of South Africa warning of the consequences of a "global abandonment of AIDS."

19 Jul 2012

AOA honors Medical College of Georgia student with Kuckein Fellowship

A student at the Medical College of Georgia at Georgia Health Sciences University is among 47 recipients of the 2012 Carolyn L. Kuckein Student Research Fellowship from the national medical honor society Alpha Omega Alpha.

19 Jul 2012

Bryologs more potent than prostratin in treating HIV

Thanks to antiretrovirals, an AIDS diagnosis hasn't been a death sentence for nearly two decades. But highly active antiretroviral therapy, or HAART, is also not a cure.

19 Jul 2012

USA Today examines recent HIV breakthroughs

USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.

19 Jul 2012

PATH Blog highlights efforts to reduce HIV in DRC

The PATH Blog reports on the organization's efforts in the Democratic Republic of Congo (DRC) "to reduce transmission of HIV, deliver integrated care and services for people affected by HIV/AIDS, and build up the country's health system to expand and improve services."

19 Jul 2012

U.S. faces problems tracking cadaver tissue donation

In the United States, almost 1.5 million medical products are used each year for surgeries made with tissue taken from cadavers. For tissue to be safe, the donor must be carefully screened.

19 Jul 2012

Better methods needed to diagnose and treat HIV, TB in children

Jennifer Furin, an infectious diseases physician and medical anthropologist who specializes in the management of tuberculosis (TB) and HIV in resource-poor settings, writes in a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog that "when it comes to the great advancements made in global HIV and TB care, children are being left behind."

19 Jul 2012

Duke-led consortium to focus on inducing neutralizing antibodies for HIV-1 prevention

Two Los Alamos National Laboratory scientists are among the team recently funded to explore ways to create the precise immune factors needed for effective vaccines against HIV.

19 Jul 2012

NPR reports on Brazilian clinical trial of Truvada as prevention strategy

NPR's "Shots" blog reports on one of the drug trials considered by the FDA in its approval of the antiretroviral drug Truvada for pre-exposure prophylaxis (PrEP) to prevent HIV among people at risk of contracting the virus, which "was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro."

19 Jul 2012

HIV 1 News and Research

Community-based resources in rural Uganda can successfully provide HIV treatments

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

CSIS official discusses upcoming AIDS 2012 conference, introduces new AIDS 2012 course on iTunes U

Scientists plan to announce research strategy aimed at pursuing HIV/AIDS cure, Wall Street Journal reports

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

International Partnership for Microbicides CEO discusses research in GlobalPost interview

PBS Newshour shares stories of those affected by HIV/AIDS epidemic

Single-step method can rapidly detect pathogens and chemical contaminants

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

BioDiem signs agreement with RMIT to create new non-influenza vaccines

UNMC's ART injectables can successfully treat HIV infection

AHF: U.S. defends Obama no-show at AIDS conference

AOA honors Medical College of Georgia student with Kuckein Fellowship

Bryologs more potent than prostratin in treating HIV

USA Today examines recent HIV breakthroughs

PATH Blog highlights efforts to reduce HIV in DRC

U.S. faces problems tracking cadaver tissue donation

Better methods needed to diagnose and treat HIV, TB in children

Duke-led consortium to focus on inducing neutralizing antibodies for HIV-1 prevention

NPR reports on Brazilian clinical trial of Truvada as prevention strategy

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News